Abstract
Background Air pollution has been recognized as an untraditional risk factor for myocardial infarction (MI). However, the MI risk attributable to long-term exposure to fine particulate matter (PM2.5) is unclear, especially in younger populations, and few studies represented the general population.
Methods We applied the difference-in-differences approach to estimate the relationship between annual PM2.5 exposure and hospitalizations for MI among U.S. residents and further identified potential susceptible subpopulations. All hospital admissions for MI in ten U.S. states over the period 2002-2016 were obtained from the Healthcare Cost and Utilization Project State Inpatient Database.
Results In total, 1,914,684 MI hospital admissions from 8,106 ZIP codes in ten states from 2002 to 2016 were included in this study. We observed a 1.35% (95% CI: 1.11-1.59%) increase in MI hospitalization rate for 1 μg/m3 increase in annual PM2.5 exposure. The estimate was robust to adjustment for surface pressure, relative humidity and co-pollutants. In the population with exposure at or below 12 μg/m3, there was a larger increment of 2.17% (95% CI: 1.79-2.56%) in hospitalization rate associated with 1 μg/m3 increase in PM2.5. Young people (0-34 years) and elderly people (≥75 years) were the two most susceptible age groups. Residents living in more densely populated or poorer areas and individuals with comorbidities were observed to be at a greater risk.
Conclusions This study indicates long-term residential exposure to PM2.5 could lead to increased risk of MI among U.S. general population. The association persists below current standards.
What is new?
Long-term exposure to PM2.5 increased the risk of myocardial infarction in the general U.S. population.
Young individuals aged 0-34 years had the highest relative risk from long-term exposure to PM2.5, and elderly people aged ≥75 years were the second most susceptible to the effects.
Individuals with iron deficiency anemia, psychosis, and renal failure were more susceptible to the long-term effects of PM2.5 on MI.
What are the clinical implications?
Long-term PM2.5 exposure is one of the important modifiable environmental risk factors for myocardial infarction, therefore, air pollution control and behavioral interventions should be taken to prevent the occurrence of myocardial infarction.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
This study used the inpatient care records from the Healthcare Cost and Utilization Program (HCUP) State Inpatient Database (SID). It did not involve any clinical trial.
Funding Statement
This work was made possible by U.S. Environmental Protection Agency (EPA) grant RD-835872. Its contents are solely the responsibility of the grantee and do not necessarily represent the official views of the U.S. EPA. Further, U.S. EPA does not endorse the purchase of any commercial products or services mentioned in the publication. This work was also supported by National Institutes of Health (NIH) grant R01 ES032418-01 and National Institute of Environmental Health Sciences (NIEHS) grant (P30 ES000002).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The institutional review board for human subjects or animal research at Harvard University has approved this study.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
The authors do not have permission to share data.
